SummaryEligible participants will receive liver radiation therapy called Stereotactic Ablative Body Radiotherapy (SABR). Kilovoltage Intrafraction Monitoring (KIM) tracking will be tested during mock treatment. If it is found to be successful, it will be used throughout treatment. If it is found to be unsuccessful, cone beam CT imaging will be used instead.
Treatment TypeRadiotherapy,Systemic therapy (chemotherapy, hormone therapy or immunotherapy)
18 - 85
Use the hyperlinks, where available to access additional clinical trial information.
University of Sydney
LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)